Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
21.28
-0.60 (-2.74%)
Apr 29, 2026, 3:06 PM CST
42.44%
Market Cap 11.54B
Revenue (ttm) 3.50B
Net Income (ttm) 128.49M
Shares Out 542.18M
EPS (ttm) 0.23
PE Ratio 93.98
Forward PE 57.51
Dividend 0.09 (0.41%)
Ex-Dividend Date n/a
Volume 21,412,885
Average Volume 14,937,433
Open 21.11
Previous Close 21.88
Day's Range 20.87 - 21.95
52-Week Range 14.75 - 30.40
Beta 0.70
RSI 46.08
Earnings Date Apr 4, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatograph... [Read more]

Sector Healthcare
Founded 2005
Employees 4,359
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.